Shares of Eden Research plc (LON:EDEN – Get Free Report) were down 7.4% during trading on Wednesday . The company traded as low as GBX 2.53 ($0.03) and last traded at GBX 2.64 ($0.04). Approximately 1,234,060 shares changed hands during trading, an increase of 150% from the average daily volume of 492,886 shares. The stock had previously closed at GBX 2.85 ($0.04).
Eden Research Stock Down 5.3%
The business’s fifty day moving average is GBX 3.28 and its two-hundred day moving average is GBX 3.27. The company has a market cap of £14.39 million, a P/E ratio of -749.44 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80.
Eden Research (LON:EDEN – Get Free Report) last released its earnings results on Wednesday, September 17th. The company reported GBX (0.25) earnings per share for the quarter. Eden Research had a negative return on equity of 11.63% and a negative net margin of 38.70%. Equities analysts predict that Eden Research plc will post -66.0000038 EPS for the current year.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Further Reading
- Five stocks we like better than Eden Research
- What Investors Need to Know About Upcoming IPOs
- Rezolute Stock: FDA Fast Track Fuels 2025 Breakout
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Is It Time to Trim Your Positions in These 2 AI Stocks?
- Are Penny Stocks a Good Fit for Your Portfolio?
- These 3 Tech Stocks Just Supercharged Their Buybacks
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.